Article citationsMore>>

M. de Perrot, C. Chaparro, K. McRae, et al., “Twenty Year Experience of Lung Transplantation at a Single Center: Influence of Recipient Diagnosis on Long-Term Survival,” Journal of Thoracic and Cardiovascular Surgery, Vol. 127, No. 5, 2004, pp. 1493-1501. doi:10.1016/j.jtcvs.2003.11.047

has been cited by the following article:

• TITLE: Lung Transplant and Outcomes: A Single-Center Experience

  AUTHORS: Iskander Al-Githmi

  KEYWORDS: Lung; Transplant; Outcomes

  JOURNAL NAME: Surgical Science, Vol.3 No.6, June 20, 2012

  ABSTRACT: Introduction: Lung transplant is the preferred treatment for several end-stage pulmonary diseases. The first successful human lung transplant was performed by the Toronto Group in 1983 [1]. Objectives: This article discusses our initial experience with single and double lung transplant. Study Design: A retrospective analysis was done on 11 consecutive lung transplants for end-stage pulmonary diseases performed at our institution between 2008 and 2010. Materials and Methods: Major indications were idiopathic pulmonary fibrosis (n = 6), bronchiectasis (n = 2), primary pulmonary hypertension (n = 1), lymphangioleiomyomatosis (n = 1), and scleroderma (n = 1). Results: Two patients (18.2%) died within 30 days of surgery. One- and 2-year survival rates for the recipients were 81.8% and 72.7%. Sepsis caused the deaths of 2 recipients. Conclusions: Although sepsis and chronic rejection limit the benefits, lung transplant gives many patients with end-stage pulmonary disease the ability for a better quality of life.